Evidence map›Paper›PMID 38962958›Full record

Trial reportAlzheimer's & dementia : the journal of the Alzheimer's Association2024

Effect of gamification with a support partner to increase physical activity in older adults at risk for Alzheimer's disease: The STEP 4Life randomized clinical trial.

S Ryan Greysen, Ai Leen Oon, Kristin Harkins, Charles Rareshide, Angira Mondal, Mitesh S Patel, Joshua D Grill, Jason Karlawish

Erratum issued Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05069155 (Gamification to Improve Physical Activity in Older Adults at Risk for Alzheimer's), which is not on this map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05069155 nacompletednot on this map

Gamification to Improve Physical Activity in Older Adults at Risk for Alzheimer's: the STEP 4Life Trial

TypeinterventionalSponsorUniversity of PennsylvaniaRan2021 to 2023Enrolled240ConditionsAlzheimer Disease, At Risk, Alzheimer Disease, Protection Against, DementiaArmsGamification
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

S Ryan GreysenDivision of Hospital Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-0123-0831
Ai Leen OonDivision of Hospital Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Kristin HarkinsPenn Memory Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Charles RareshideCenter for Healthcare Incentives and Behavioral Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Angira MondalLeonard Davis Institute, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Mitesh S PatelOffice of Clinical Transformation, Ascension Health, St. Louis, St. Louis, Missouri, USA.
Joshua D GrillDepartment of Neurobiology and Behavior, University of California Irvine, Irvine, California, USA.
Jason KarlawishPenn Memory Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Funding

Research Education ComponentP30AG072979 · NIA · UNIVERSITY OF PENNSYLVANIA · PI DAVID A WOLK · 2021 to 2026
$24.8M
USC-Yale Roybal Center for Behavioral Interventions in AgingP30AG024968 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JASON N. DOCTOR · 2004 to 2026
$14.7M
STATISTICAL DATA ENCLAVE COREP30AG012836 · NIA · UNIVERSITY OF PENNSYLVANIA · PI COE, NORMA B, KOHLER, HANS-PETER · 1999 to 2024
$14.0M
Center for Health Incentives and Behavioral Economics (CHIBE)NIA NIH HHS P30 AG012836NIA NIH HHS P30 AG024968NIA NIH HHS P30 AG072979Population Aging Research Center 5P30AG012836-20University of PennsylvaniaUniversity of Southern California Roybal Center for Behavioral Interventions in Aging 5P30AG024968-20
6 · The paper itself

Abstract

introductionPhysical activity is associated with reduced risk of cognitive and functional decline but scalable, sustainable interventions for populations at risk for Alzheimer's disease (AD) and AD and related dementias (ADRD) are lacking.

methodsA 12-week randomized-controlled trial was conducted with a 3-week follow-up using a national AD prevention registry (GeneMatch). The control group (n = 50) set step goals and received daily feedback. The intervention group (n = 44) also received a behaviorally designed game based on achieving step goals and reinforced by a support partner.

resultsIntervention participants (94 participants, mean age 70, 78% female) had greater change in mean daily step count than control of 1699 steps/day (95% confidence interval [CI], 1149-2249), P < 0.0001, which was sustained in the follow-up period at 1219 steps/day (95% CI, 455-1983), P = 0.0018. Carriers of the apolipoprotein E ε4 gene (high risk) did not perform differently than non-carriers; however, high self-reported risk perception was associated with higher activity. DISCUSSION: A gamified intervention was effective in promoting and sustaining higher physical activity in older adults at genetic risk for AD/ADRD. HIGHLIGHTS: A simple game played with a support partner increased walking in older adults at risk for Alzheimer's disease (AD). The game also increased minutes of moderate-to-vigorous physical activity per day. Perception of lifelong AD risk was associated with increased activity but genetic risk (apolipoprotein E ε4+) was not.

trial registrationClinicalTrials.gov: NCT05069155.

Indexed as

Alzheimer DiseaseExerciseAgedFemaleHumansMaleAlzheimer's diseasebehavioral economicsdementiagamificationphysical activity

Identifiers

PMID38962958
PMCPMC11350015

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.